187 results on '"Jayaseelan, Vijayashree Priyadharsini"'
Search Results
2. N6-methyladenosine-mediated overexpression of TREM-1 is associated with periodontal disease
3. Biallelic loss-of-function variations in BTD cause profound biotinidase deficiency in an Indian patient
4. Aberrated PSMA1 expression associated with clinicopathological features and prognosis in oral squamous cell carcinoma
5. Microbial signatures in head and neck squamous cell carcinoma: an in silico study
6. A novel m6A reader RBFOX2 expression is increased in oral squamous cell carcinoma and promotes tumorigenesis
7. NKAP: A new m6A RNA binding protein predicts prognosis and immunotherapy response in head and neck squamous cell carcinoma
8. Dysregulation of a novel m6A regulator YWHAG is correlated with metastasis and poor prognosis in oral squamous cell carcinoma – A cross-sectional study
9. Altered expression of insulin-like growth factor 2 mRNA binding protein 2 is associated with periodontal disease- a case-control analysis
10. DYNC1I1 acts as a promising prognostic biomarker and is correlated with immune infiltration in head and neck squamous cell carcinoma
11. Overexpression of insulin-like growth factor-2 mRNA-binding protein 1 is associated with periodontal disease
12. Aberrant expression of VASP serves as a potential prognostic biomarker and therapeutic target for oral squamous cell carcinoma
13. RFC3 serves as a novel prognostic biomarker and target for head and neck squamous cell carcinoma
14. Alteration of SERPINH1 is associated with elevated expression in head and neck squamous cell carcinomas and its clinicopathological significance
15. Triggering receptor expressed in myeloid cells 1 (TREM1) as a potential prognostic biomarker and association with immune infiltration in oral squamous cell carcinoma
16. EXT2: a novel prognostic and predictive biomarker for head and neck squamous cell carcinoma
17. Expression of CD44 in Head and Neck Squamous Cell Carcinoma—An In-Silico Study
18. Alteration in PNMA1 expression is associated with poor prognosis and tumor immune infiltration in head and neck squamous cell carcinoma
19. Deciphering the Genetic Alterations in PIK3CA Gene Interacting Network and Their Putative Association with Breast Cancer: A Computational Approach.
20. Biallelic loss-of-function variations in BTD cause profound biotinidase deficiency in an Indian patient
21. METTL3 as a potential predictive biomarker for immunotherapy response in metastatic head and neck cancer.
22. Aberrations of m6A regulators are associated with tumorigenesis and metastasis in head and neck squamous cell carcinoma
23. Breast cancer and DDT: putative interactions, associated gene alterations, and molecular pathways
24. Correlating the Genetic Alterations and Expression Profile of the TRA2B Gene in HNSCC and LUSC.
25. The novel m6A writer methyltransferase 5 is a promising prognostic biomarker and associated with immune cell infiltration in oral squamous cell carcinoma.
26. Abstract 13959: Role of METTL3 in Regulating Pulmonary Hypertension via Controlling GLUT4 mRNA Translation
27. Emerging role of exosomes as promising diagnostic tool for cancer
28. GLUT1 Expression in Oral Squamous Cell Carcinoma and Its Significance.
29. Computational Evaluation on the Interactions of an Opaque-Phase ABC Transporter Associated with Fluconazole Resistance in Candida albicans, by the Psidium guajava Bio-Active Compounds.
30. Prognostic and clinicopathological significance of MRC2 expression in head and neck squamous cell carcinoma
31. DYNC1I1 acts as a promising prognostic biomarker and is correlated with immune infiltration in head and neck squamous cell carcinoma
32. Pathogenic loss-of-function mutations in LRP1B are associated with poor survival in head and neck cancer patients
33. Emerging role of NET inhibitors in cardiovascular diseases
34. Targeted protein degradation as an innovative therapeutic modality for oral squamous cell carcinoma
35. Proteolysis-targeting chimeras targeting epigenetic modulators: a promising strategy for oral cancer therapy
36. EXT2: A novel prognostic and predictive biomarker for Head and Neck Squamous Cell Carcinoma
37. Decreased expression of the m6A RNA methyltransferase METTL3 is associated with residual ridge resorption
38. Post-transcriptional gene silencing by nucleic acid gapmers: a promising therapeutic modality for cancer
39. Repurposing calcium channel blockers as antiviral drugs
40. An Investigation on the Genetic Alterations of the ALG3 Gene and Their Possible Correlation with the Development of HNSCC and LUSC.
41. Immunotherapy for oral cancer treatment through targeting of IDO1 and its pathway
42. Exosomal microRNAs Targeting TP53 Gene as Promising Prognostic Markers for Head and Neck Squamous Cell Carcinoma
43. Exosomal microRNAs as a promising theragnostic tool for essential hypertension
44. Dissecting the theranostic potential of exosomes in autoimmune disorders
45. Role of exosomal mitochondria in cardiovascular diseases
46. Emerging Role of RNA m5C Modification in Cardiovascular Diseases
47. A Rare Biotinidase Deficiency in the Pediatrics Population: Genotype–Phenotype Analysis
48. Epigenetic modulator LSD1, a theragnostic target for potentially malignant oral disorders and malignant lesions
49. Stem cells and cell derived exosomal biomarkers as promising therapeutic components for temporomandibular joint disorders
50. Advances in oral cancer early diagnosis and treatment strategies with liquid biopsy-based approaches
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.